An Engineered Non-Toxic Superantigen Increases Cross Presentation of Hepatitis B Virus Nucleocapsids by Human Dendritic Cells

• Julie D. McIntosh,

  Affiliation School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand

  ⨯
• Kristy Manning,

  Affiliation School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand

  ⨯
• Shilpa Chokshi,

  Affiliation Institute of Hepatology, University College London, London, United Kingdom

  ⨯
• Nikolai V. Naoumov,

  Current address: Novartis Pharma AG, Basel, Switzerland

  Affiliation Institute of Hepatology, University College London, London, United Kingdom

  ⨯
• John D. Fraser,

  Affiliation School of Medical Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand

  ⨯
• P. Rod Dunbar,

  Affiliation School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand

  ⨯
• John A. Taylor

  * E-mail: ja.taylor@auckland.ac.nz

  Affiliation School of Biological Sciences and Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand

  ⨯